EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comprehensive Pharmacological Management of Wilson’s Disease: Mechanisms, Clinical Strategies, and Emerging Therapeutic Innovations

Ralf Weiskirchen

Sci · 01.07.2025 · 7 (3) · 94

DOI: 10.3390/sci7030094 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sci, online erschienen am 01.07.2025. Verfasst von Ralf Weiskirchen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation, Deutsche Krebshilfe, Interdisciplinary Centre for Clinical Research within the Faculty of Medicine at the RWTH Aachen University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Wilson’s disease is a rare autosomal recessive disorder of copper metabolism characterized by excessive copper accumulation in the liver, brain, and other tissues. This paper provides an overview of the primary pharmacological agents used in its treatment, including penicillamine, trientine, tetrathiomolybdate, and zinc. Their mechanisms of action, therapeutic applications, and side-effect profiles are examined, emphasizing how each agent helps reduce copper overload. Additionally, brief information is given on novel therapies such as gene therapy and artificial intelligence applications. Furthermore, information about the structural and chemical properties of these compounds is provided, highlighting the molecular features that enable them to chelate copper or reduce its intestinal absorption. By integrating pathophysiological insights with chemical and mechanistic perspectives, this paper offers a comprehensive review of existing treatment strategies for Wilson’s disease and stresses the importance of careful, patient-specific management to optimize long-term outcomes.

Förderung

  • German Research Foundation
  • Deutsche Krebshilfe
  • Interdisciplinary Centre for Clinical Research within the Faculty of Medicine at the RWTH Aachen University

Zitieren

APA

Weiskirchen, R. (2025). Comprehensive Pharmacological Management of Wilson’s Disease: Mechanisms, Clinical Strategies, and Emerging Therapeutic Innovations. Sci, 7(3), 94. https://doi.org/10.3390/sci7030094

Vancouver

Weiskirchen R. Comprehensive Pharmacological Management of Wilson’s Disease: Mechanisms, Clinical Strategies, and Emerging Therapeutic Innovations. Sci. 2025;7(3):94. doi:10.3390/sci7030094

BibTeX
@article{Weiskirchen2025,
  author = {Weiskirchen, Ralf},
  title = {Comprehensive Pharmacological Management of Wilson’s Disease: Mechanisms, Clinical Strategies, and Emerging Therapeutic Innovations},
  journal = {Sci},
  year = {2025},
  volume = {7},
  number = {3},
  pages = {94},
  doi = {10.3390/sci7030094}
}
Kostenlos starten →